{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:35:06Z","timestamp":1787564106606,"version":"build-2736575974"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Microsatellite stable (MSS) gastric cancer (GC) responds poorly to immunotherapy and exhibits heterogeneous outcomes. Histone lactylation plays a critical role in cancer progression. However, the prognostic and therapeutic potential of a lactylation-related gene signature (LRGS) in MSS GC remains largely unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data of MSS GC patients were obtained from The Cancer Genome Atlas and Gene Expression Omnibus databases. Consensus clustering based on lactylation-related gene expression profiles was performed to stratify patients. We further constructed the LRGS using machine learning algorithms. We also assessed its correlations with clinicopathological parameters, the tumor microenvironment, and chemosensitivity. The Tumor Immune Dysfunction and Exclusion (TIDE) algorithm was employed to predict potential responses to immunotherapy. Single-cell analysis, cell-cell communication analysis, in silico knockout, and immunohistochemical validation were integrated to explore the functional roles of key genes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Consensus clustering uncovered two clusters with significantly different overall survival outcomes. A nine-gene LRGS was established and effectively stratified patients into high- and low-risk groups. The high-risk group displayed an immunosuppressive microenvironment, reduced chemosensitivity, and higher TIDE scores. Single-cell analysis revealed that LRGS scores were highest in cancer-associated fibroblasts (CAFs), with\n                      <jats:italic>APOD<\/jats:italic>\n                      and\n                      <jats:italic>SERPINE1<\/jats:italic>\n                      highly expressed in PDGFRA+ CAFs and CA9+ CAFs, respectively. Cell-cell communication analysis showed that these two CAF subtypes exhibited distinct signaling patterns via the COLLAGEN and MIF pathways. In silico knockout further validated that\n                      <jats:italic>APOD<\/jats:italic>\n                      and\n                      <jats:italic>SERPINE1<\/jats:italic>\n                      are essential for matrix remodeling and hypoxia adaptation in their respective CAF subtypes. Immunohistochemical analysis confirmed elevated protein levels of\n                      <jats:italic>APOD<\/jats:italic>\n                      and\n                      <jats:italic>SERPINE1<\/jats:italic>\n                      in MSS GC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study developed and validated a robust LRGS for MSS GC. This signature facilitates accurate prognosis prediction and shows potential to predict responses to both chemotherapy and immunotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1838771","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:04:50Z","timestamp":1779343490000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of a lactylation-related gene signature in microsatellite stable gastric cancer based on bulk and single-cell RNA-seq"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhong-Tai","family":"Lin","sequence":"first","affiliation":[{"name":"The Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital","place":["Fuzhou, Fujian, China"]},{"name":"Department of Gastrointestinal Surgery, Fuzhou University Affiliated Provincial Hospital","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Chun","family":"Chen","sequence":"additional","affiliation":[{"name":"The Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital","place":["Fuzhou, Fujian, China"]},{"name":"Department of Gastroenterology, Fuzhou University Affiliated Provincial Hospital","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Sheng","family":"You","sequence":"additional","affiliation":[{"name":"The Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital","place":["Fuzhou, Fujian, China"]},{"name":"Department of Pathology, Fuzhou University Affiliated Provincial Hospital","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Zhao","family":"Wang","sequence":"additional","affiliation":[{"name":"The Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital","place":["Fuzhou, Fujian, China"]},{"name":"Department of Gastrointestinal Surgery, Fuzhou University Affiliated Provincial Hospital","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"The Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital","place":["Fuzhou, Fujian, China"]},{"name":"Department of Gastrointestinal Surgery, Fuzhou University Affiliated Provincial Hospital","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Jie","family":"Chi","sequence":"additional","affiliation":[{"name":"The Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital","place":["Fuzhou, Fujian, China"]},{"name":"Department of Gastrointestinal Surgery, Fuzhou University Affiliated Provincial Hospital","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): A randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.28463","article-title":"First-line sugemalimab plus chemotherapy for advanced gastric cancer: The GEMSTONE-303 randomized clinical trial","volume":"333","author":"Zhang","year":"2025","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13045-024-01536-7","article-title":"Perioperative versus adjuvant S-1 plus oxaliplatin chemotherapy for stage II\/III resectable gastric cancer (RESONANCE): A randomized, open-label, phase 3 trial","volume":"17","author":"Wang","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.19918","article-title":"Sintilimab plus chemotherapy for unresectable gastric or gastroesophageal junction cancer: The ORIENT-16 randomized clinical trial","volume":"330","author":"Xu","year":"2023","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","article-title":"Gastric cancer treatment: Recent progress and future perspectives","volume":"16","author":"Guan","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing profiles of cancer burden worldwide and in China: A secondary analysis of the global cancer statistics 2020","volume":"134","author":"Cao","year":"2021","journal-title":"Chin Med J (Engl)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114601","article-title":"Metabolic codependencies in the tumor microenvironment and gastric cancer: Difficulties and opportunities","volume":"162","author":"Zhao","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","year":"2014","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-1408","article-title":"Personalized antibodies for gastroesophageal adenocarcinoma (PANGEA): A phase II study evaluating an individualized treatment strategy for metastatic disease","volume":"11","author":"Catenacci","year":"2021","journal-title":"Cancer Discov"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.pharmthera.2018.04.004","article-title":"DNA mismatch repair in cancer","volume":"189","author":"Baretti","year":"2018","journal-title":"Pharmacol Ther"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00686","article-title":"Neoadjuvant nivolumab plus ipilimumab and adjuvant nivolumab in localized deficient mismatch repair\/microsatellite instability-high gastric or esophagogastric junction adenocarcinoma: The GERCOR NEONIPIGA phase II study","volume":"41","author":"Andr\u00e9","year":"2023","journal-title":"J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0101-z","article-title":"Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer","volume":"24","author":"Kim","year":"2018","journal-title":"Nat Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1001\/jamaoncol.2021.0275","article-title":"Assessment of pembrolizumab therapy for the treatment of microsatellite instability-high gastric or gastroesophageal junction cancer among patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 clinical trials","volume":"7","author":"Chao","year":"2021","journal-title":"JAMA Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.7150\/jca.40500","article-title":"Expression of PD1\/PDL1 in gastric cancer at different microsatellite status and its correlation with infiltrating immune cells in the tumor microenvironment","volume":"12","author":"Wang","year":"2021","journal-title":"J Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.213","article-title":"Microsatellite instable vs stable colon carcinomas: Analysis of tumour heterogeneity, inflammation and angiogenesis","volume":"113","author":"De Smedt","year":"2015","journal-title":"Br J Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01124","article-title":"Individual patient data meta-analysis of the value of microsatellite instability as a biomarker in gastric cancer","volume":"37","author":"Pietrantonio","year":"2019","journal-title":"J Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3850","article-title":"Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes","volume":"21","author":"Cristescu","year":"2015","journal-title":"Nat Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-020-0243-4","article-title":"Lactate: The ugly duckling of energy metabolism","volume":"2","author":"Rabinowitz","year":"2020","journal-title":"Nat Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI174587","article-title":"The alanyl-tRNA synthetase AARS1 moonlights as a lactyltransferase to promote YAP signaling in gastric cancer","volume":"134","author":"Ju","year":"2024","journal-title":"J Clin Invest"},{"key":"B22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00018-025-05955-8","article-title":"Histone lactylation drives METTL3 upregulation-mediated RNA m6A modification of CCT2 to hinder CD8+ T cell survival in gastric cancer","volume":"83","author":"Qian","year":"2025","journal-title":"Cell Mol Life Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s10120-025-01685-9","article-title":"Histone H4K8 lactylation modulated immunosuppressive properties by promoting FAP transcription and ECM remodeling","volume":"29","author":"Huang","year":"2026","journal-title":"Gastric Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2026.218303","article-title":"Treg-driven magnetic resonance radiomics in glioblastoma: a multicenter and cross-species model for prognostic biomarker discovery","volume":"642","author":"Wang","year":"2026","journal-title":"Cancer Lett"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-022-01523-1","article-title":"Cyclic immonium ion of lactyllysine reveals widespread lactylation in the human proteome","volume":"19","author":"Wan","year":"2022","journal-title":"Nat Methods"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/ph16050644","article-title":"Lactylation-related gene signature effectively predicts prognosis and treatment responsiveness in hepatocellular carcinoma","volume":"16","author":"Cheng","year":"2023","journal-title":"Pharm (Basel)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abi6696","article-title":"Class I histone deacetylases (HDAC1-3) are histone lysine delactylases","volume":"8","author":"Moreno-Yruela","year":"2022","journal-title":"Sci Adv"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-023-01185-x","article-title":"STING is a cell-intrinsic metabolic checkpoint restricting aerobic glycolysis by targeting HK2","volume":"25","author":"Zhang","year":"2023","journal-title":"Nat Cell Biol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-020-0168-0","article-title":"Acetylation promotes BCAT2 degradation to suppress BCAA catabolism and pancreatic cancer growth","volume":"5","author":"Lei","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-026-03688-x","article-title":"Interstitial cystitis-related gene CCDC8 accelerates tumorigenesis by participating in CUL7-mediated degradation of P53 in bladder cancer","volume":"45","author":"Wang","year":"2026","journal-title":"Oncogene"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.003187","article-title":"ATP-binding cassette member B5 (ABCB5) promotes tumor cell invasiveness in human colorectal cancer","volume":"293","author":"Guo","year":"2018","journal-title":"J Biol Chem"},{"key":"B33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2016.11.005","article-title":"Nerve growth factor promotes gastric tumorigenesis through aberrant cholinergic signaling","volume":"31","author":"Hayakawa","year":"2017","journal-title":"Cancer Cell"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/biom12121805","article-title":"Alteration of cellular energy metabolism through LPAR2-Axin2 axis in gastric cancer","volume":"12","author":"Ara","year":"2022","journal-title":"Biomolecules"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12911","article-title":"LncRNA NKX2-1-AS1 promotes tumor progression and angiogenesis via upregulation of SERPINE1 expression and activation of the VEGFR-2 signaling pathway in gastric cancer","volume":"15","author":"Teng","year":"2021","journal-title":"Mol Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03269-4","article-title":"Gastric cancer-derived exosomal let-7 g-5p mediated by SERPINE1 promotes macrophage M2 polarization and gastric cancer progression","volume":"44","author":"Ye","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2024.02.015","article-title":"Uncovering the potential of APOD as a biomarker in gastric cancer: A retrospective and multi-center study","volume":"23","author":"Wang","year":"2024","journal-title":"Comput Struct Biotechnol J"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: From immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa176","article-title":"Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response","volume":"22","author":"Hu","year":"2021","journal-title":"Brief Bioinform"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-1714","article-title":"Spatial positioning and matrix programs of cancer-associated fibroblasts promote T-cell exclusion in human lung tumors","volume":"12","author":"Grout","year":"2022","journal-title":"Cancer Discov"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-4141","article-title":"Cancer-associated fibroblasts suppress CD8+ T-cell infiltration and confer resistance to immune-checkpoint blockade","volume":"82","author":"Jenkins","year":"2022","journal-title":"Cancer Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-23-0426","article-title":"Senescent CAFs mediate immunosuppression and drive breast cancer progression","volume":"14","author":"Ye","year":"2024","journal-title":"Cancer Discov"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18579","article-title":"Pan-cancer analysis of SERPINE1 with a concentration on immune therapeutic and prognostic in gastric cancer","volume":"28","author":"Ju","year":"2024","journal-title":"J Cell Mol Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202500136","article-title":"SERPINE1 facilitates metastasis in gastric cancer through anoikis resistance and tumor microenvironment remodeling","volume":"21","author":"Wang","year":"2025","journal-title":"Small"},{"key":"B46","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s10565-025-10050-6","article-title":"NFATC2\/SERPINE1\/JAK3\/STAT3 signaling feedback loop in gastric cancer: Immune evasion and anti-PD-1 resistance","volume":"41","author":"Yang","year":"2025","journal-title":"Cell Biol Toxicol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.ccell.2024.08.020","article-title":"Cross-tissue human fibroblast atlas reveals myofibroblast subtypes with distinct roles in immune modulation","volume":"42","author":"Gao","year":"2024","journal-title":"Cancer Cell"},{"key":"B48","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12943-023-01876-x","article-title":"Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment","volume":"22","author":"Ma","year":"2023","journal-title":"Mol Cancer"},{"key":"B49","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1186\/s12967-024-05564-2","article-title":"The multifaceted role of the stroma in the healthy prostate and prostate cancer","volume":"22","author":"Di Carlo","year":"2024","journal-title":"J Transl Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122900","article-title":"Matrix stiffening from collagen fibril density and alignment modulates YAP-mediated T-cell immune suppression","volume":"315","author":"Sapudom","year":"2025","journal-title":"Biomaterials"},{"key":"B51","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/mdr2.70038","article-title":"Single-cell transcriptomic analysis reveals epithelial-mesenchymal transition and key gene AGRN as a universal programme in gastrointestinal tumours by an artificial intelligence-derived prognostic index","volume":"2","author":"Ni","year":"2026","journal-title":"Med Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102181","article-title":"Methionine restriction promotes the polarization of macrophages towards M1 and the immunotherapy effect of PD-L1\/PD-1 blockades by inhibiting the secretion of MIF by gastric carcinoma cells","volume":"51","author":"Xin","year":"2025","journal-title":"Transl Oncol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1636839","article-title":"Macrophage migration inhibitory factor (MIF) and the tumor ecosystem: a tale of inflammation, immune escape, and tumor growth","volume":"16","author":"Youness","year":"2025","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-3164","article-title":"Single-cell transcriptomic landscape deciphers intratumoral heterogeneity and subtypes of acral and mucosal melanomas","volume":"31","author":"Li","year":"2025","journal-title":"Clin Cancer Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1838771\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:04:51Z","timestamp":1779343491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1838771\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2026.1838771"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1838771","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"article-number":"1838771"}}